File A08459 ("Expands opioid settlement reach to entire supply chain") is before the New York Legislature and has not been decided. Latest step (June 10, 2025): substituted by s6757.
New York file A08459, before the New York Legislature. No action in 525 days as of 2025-06-10.
More defendants means larger settlement pool for state programs By explicitly including all entities in the prescription drug marketing, supply, and payment chain involved in illegal conduct, the bill increases the number of potentially liable parties, which could grow the total settlement funds available for opioid treatment and prevention programs in your state.
Pharmacies, insurers, and distributors face expanded liability exposure Beyond manufacturers, the bill clarifies that wholesalers, pharmacies, pharmacy benefit managers, and insurance companies involved in the supply and payment chain can now be pursued through settlement agreements, reshaping industry-wide accountability for the opioid crisis.
Litigation risk could trigger corporate exits or price increases Expanded liability may prompt some smaller pharmacies or regional distributors to withdraw from markets or raise prices to cover litigation costs, potentially reducing local access or increasing out-of-pocket expenses in rural or underserved areas.
Read the official record for A08459
See everything up for a vote · This week in New York · See what we have filed with the clerk